Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos.
Zala M, Lipinski B, Costechareyre C, Jarrosson L, Teinturier R, Julia E, Lacourrège M, Verney A, Guitton J, Traverse-Glehen A, Bachy E, Salles G, Huet S, Genestier L, Castellani V, Delloye-Bourgeois C, Sujobert P. Zala M, et al. Among authors: genestier l. Leukemia. 2024 Feb;38(2):430-434. doi: 10.1038/s41375-024-02150-9. Epub 2024 Jan 15. Leukemia. 2024. PMID: 38225454 Free PMC article.
A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.
Al Assi A, Posty S, Lamarche F, Chebel A, Guitton J, Cottet-Rousselle C, Prudent R, Lafanechère L, Giraud S, Dallemagne P, Suzanne P, Verney A, Genestier L, Castets M, Fontaine E, Billaud M, Cordier-Bussat M. Al Assi A, et al. Among authors: genestier l. Cell Death Dis. 2024 May 2;15(5):311. doi: 10.1038/s41419-024-06668-9. Cell Death Dis. 2024. PMID: 38697987 Free PMC article.
Deep phenotyping of nodal T-cell lymphomas reveals immune alterations and therapeutic targets.
Stephan P, Perrot J, Voisin A, Barbery M, Andrieu T, Grimont M, Caramel J, Bardou M, Tondeur G, Missiaglia E, Gaulard P, Lemmonier F, De Leval L, Bachy E, Sujobert P, Genestier L, Traverse-Glehen A, Grinberg-Bleyer Y. Stephan P, et al. Among authors: genestier l. Haematologica. 2024 May 30. doi: 10.3324/haematol.2023.284448. Online ahead of print. Haematologica. 2024. PMID: 38813724 Free article.
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Decroos A, Cheminant M, Bruneau J, Carras S, Parinet V, Pelletier L, Lacroix L, Martin N, Giustiniani J, Lhermitte L, Asnafi V, Battistella M, Lemonnier F, De Leval L, Sicard H, Bonnafous C, Gauthier L, Genestier L, Caruso S, Gaulard P, Hermine O, Ortonne N. Decroos A, et al. Among authors: genestier l. Haematologica. 2023 Oct 1;108(10):2830-2836. doi: 10.3324/haematol.2022.282220. Haematologica. 2023. PMID: 37165836 Free PMC article. No abstract available.
ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.
Andrieu GP, Hypolite G, Latiri M, Balducci E, Costa C, Verhoeyen E, Courgeon M, Allatif O, Nemazanyy I, Panasyuk G, Wellen KE, Herranz D, Genestier L, Macintyre EA, Asnafi V, Tesio M. Andrieu GP, et al. Among authors: genestier l. Blood Adv. 2024 Nov 15:bloodadvances.2024013762. doi: 10.1182/bloodadvances.2024013762. Online ahead of print. Blood Adv. 2024. PMID: 39546747
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses.
von Jan J, Timonen S, Braun T, Jiang Q, Ianevski A, Peng Y, McConnell K, Sindaco P, Müller TA, Pützer S, Klepzig H, Jungherz D, Dechow A, Wahnschaffe L, Giri AK, Kankainen M, Kuusanmäki H, Neubauer HA, Moriggl R, Mazzeo P, Schmidt N, Koch R, Hallek M, Chebel A, Armisen D, Genestier L, Bachy E, Mishra A, Schrader A, Aittokallio T, Mustjoki S, Herling M. von Jan J, et al. Among authors: genestier l. Blood. 2024 Oct 10;144(15):1595-1610. doi: 10.1182/blood.2023022884. Blood. 2024. PMID: 38941598
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice.
Moreews M, Mathieu AL, Pouxvielh K, Reuschlé Q, Drouillard A, Dessay P, Meignien M, Zhang J, Fallone L, Rousseaux N, Ainouze M, Rey A, Omarjee O, Decembre E, Lenief V, Djebali S, Thaunat O, Dreux M, Genestier L, Defrance T, Soulas-Sprauel P, Marçais A, Walzer T, Belot A. Moreews M, et al. Among authors: genestier l. J Immunol. 2023 May 1;210(9):1209-1221. doi: 10.4049/jimmunol.2200818. J Immunol. 2023. PMID: 36961448
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.
Delage L, Lambert M, Bardel É, Kundlacz C, Chartoire D, Conchon A, Peugnet AL, Gorka L, Auberger P, Jacquel A, Soussain C, Destaing O, Delecluse HJ, Delecluse S, Merabet S, Traverse-Glehen A, Salles G, Bachy E, Billaud M, Ghesquières H, Genestier L, Rouault JP, Sujobert P. Delage L, et al. Among authors: genestier l. Blood. 2023 Mar 9;141(10):1209-1220. doi: 10.1182/blood.2022016943. Blood. 2023. PMID: 36375119 Free article.
KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target.
Cheminant M, Lhermitte L, Bruneau J, Sicard H, Bonnafous C, Touzart A, Bourbon E, Ortonne N, Genestier L, Gaulard P, Palmic P, Suarez F, Frenzel L, Naveau L, Bazarbachi A, Dussiot M, Waast L, Avettand-Fenoel V, Brouzes C, Pique C, Lepelletier Y, Asnafi V, Marçais A, Hermine O. Cheminant M, et al. Among authors: genestier l. Blood. 2022 Sep 29;140(13):1522-1532. doi: 10.1182/blood.2022016765. Blood. 2022. PMID: 35687761 Free article. Clinical Trial.
74 results